Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Symkevi in children with cystic fibrosis
NL-OMON20087Not yet recruiting
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tezacaftor + ivacaftor, tezacaftor and ivacaftor in cystic fibrosis (CF), sponsored by None. Planned start May 2021; status: not yet recruiting.
02
Drugs
tezacaftor + ivacaftortezacaftorivacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NL-OMON20087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20087.